Synthesis of albumin-dextran sulfate microspheres possessing favourable loading and release characteristics for the anticancer drug doxorubicin

https://doi.org/10.1016/0168-3659(94)90250-XGet rights and content

Abstract

Doxorubicin (DOX), commonly used in cancer chemotherapy, produces undesirable side effects such as cardiotoxicity. To minimise these, attempts have been made to improve targeting of the drug by using microparticulate carriers to deliver DOX to the tumour site. Much of the work so far performed has used albumin based microspheres as they are non-toxic and biodegradable. In a continuation of this research, we report the synthesis of an albumin-dextran sulfate microsphere with very favourable loading (payloads up to 84%) and release characteristics for the drug DOX. A variety of release profiles for these microspheres can be obtained by loading the particles to different extents. These profiles can be further modified by treating the loaded microspheres with Fe(III) which retards the release of DOX. This versatility in the release profiles of these particles offers promise for their use in the clinical treatment of tumours.

References (14)

There are more references available in the full text version of this article.

Cited by (46)

  • Protein and peptide delivery through glycogen and dextran

    2023, Peptide and Protein Drug Delivery Using Polysaccharides
  • Lipid-polymer nano core-shell type hybrid system for colon specific drug delivery

    2021, Journal of Drug Delivery Science and Technology
    Citation Excerpt :

    Solid lipid nanoparticulate systems (SLNPs) are advanced nano lipid carrier systems in addition to the traditional ones such as liposomes, lipid emulsions, and polymeric nanoparticles [22]. SLNPs have adequate tolerability, scaling-up utility, ability to integrate hydrophobic or hydrophilic drugs, and have an enriched stability of encapsulated drugs [22–30]. The aim of the current work is to formulate, optimize and characterize (using both in vitro and in vivo studies) mesalamine loaded solid lipid drug delivery systems to address formulation and treatment related issues in oral delivery by developing controlled SLNP drug delivery systems.

  • Potential of Cationic-Polymeric Nanoparticles for Oral Delivery of Naringenin: In Vitro and In Vivo Investigations

    2018, Journal of Pharmaceutical Sciences
    Citation Excerpt :

    The %EE and %DL depend on drug solubility in the excipients matrix material (solid polymer or liquid dispersion agent), which is related to the matrix composition, molecular weight, drug-polymer interactions, and the presence of end functional groups in either the drug or matrix.49-51 For small molecules like NRG, studies show the use of ionic interaction between the drug and matrix materials can be very effective in increasing %EE and %DL.52,53 The surface morphology of optimized NRG-EE100-NPs was determined by HR-TEM micrographs.

  • Recent advances in nanoparticle-mediated drug delivery

    2017, Journal of Drug Delivery Science and Technology
    Citation Excerpt :

    The macromolecule displays greatest loading efficiency when it is loaded at or near its isoelectric point where it has lower solubility and high adsorption. For the molecules smaller in size, studies demonstrate the role of ionic interaction between the drug and matrix materials can be a very effective way to increase the drug loading [60]. To develop a successful nano-drug carrier system, both drug expulsion and polymer biodegradation are importantly considered.

  • Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives

    2017, Drug Discovery Today
    Citation Excerpt :

    For drug targeting, nanocarrier surface chemistry plays an important part in improving the circulation time of nanocarriers in blood. During the past decade, a great deal of surface modification has been attempted to develop the so-called ‘stealth’ particles or PEGylated NPs, which can escape from macrophages or phagocytes [12]. A variety of nanosystems including synthetic biodegradable polymers, such as chitosan (CS), polycaprolactone (PCL) or poly-lactic-co-glycolic acid (PLGA), lipids (liposomes, nano-liposomes, solid-lipid NPs), and other nanosystems including mesoporous silica NPs (MSNs), micelles, quantum dots (QDs), carbon nanotubes (CNTs) [13] and iron oxide magnetic nanoparticles (MNPs) have been investigated.

View all citing articles on Scopus

A provisional patent on this work has been lodged in Australia (PM2492).

View full text